GPT and metabolic dysfunction-associated steatotic liver disease: The same meta-analysis reported that these patients have the highest prevalence of fibrosis (as measured by elastography or FIB-4 > 2.67) of 10.2% (vs 4.9% in the overlap group, 3.2% in patients without steatosis, and 2.2% in NAFLD only group), as well as higher ALT and AST compared to NAFLD.